Led by Christine Burt Solorzano, MD, the TrialNet team at University of Virginia Health System is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Virginia Health System is regionally overseen by University of Pittsburgh. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Our Team

Christine Burt Solorzano Solorzano, MD

Principal Investigator

Gabrielle A Laskey, MA, CCRC

Clinical Research Coordinator